Ubrelvy (ubrogepant) and Nurtec (rimegepant) are prescription medications approved to help manage and offer relief for people dealing with migraine headaches with or without aura. Both belong to a ...

They can help you decide if one of these medications is right for you. Ubrelvy, Nurtec ODT, and Imitrex are all used to treat migraine episodes that occur with or without aura. Ubrelvy and Nurtec ...

The latter isn't going to happen of course. AbbVie recorded sales of more than $1.2 billion for Ubrelvy and partner migraine drug Qulipta for episodic and chronic migraine prevention last year.

AbbVie sells another oral CGRP called Ubrelvy (ubrogepant) for acute treatment of migraine, which made around $552 million last year, and hasn't yet disclosed Qulipta's quarterly sales performance.